Clinical Trials Browser

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Brain Neoplasms, Melanoma

Carcinoma, Hepatocellular

Ovarian Neoplasms

Multi-organ Metastatic Colorectal Cancer

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular, Liver Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

Colorectal Neoplasms

Glioblastoma

Glioblastoma

Non-small Cell Lung Cancer Metastatic

Colorectal Neoplasms

Glioblastoma

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Central Nervous System Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Advanced Non-squamous Non-Small Cell Lung Cancer

Breast Neoplasms, Breast Neoplasms, Male

Prostatic Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Brain Neoplasms, Glioma

Glioblastoma

Rectal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Lung Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Colonic Neoplasms

Carcinoma, Renal Cell

Glioma, Recurrence

Breast Neoplasms, Breast Neoplasms, Male

Breast Neoplasms

Carcinoma, Renal Cell

Hypertension, Neoplasms

Hypertension, Neoplasms

Clinical Trials

Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases

ICT-HCC

SCENIC

ORCHESTRA

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

DEBIRI

Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy

Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients

BABST-C

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

BETTER

Escalated Dose of Irinotecan in mCRC

FMISO PET Study of Glioblastoma

ATTRACT

The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

AVF4759

TC Avastin. ICORG 08-10, V6

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

AVECC

Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer

MORE

Radiosurgery and Avastin for Recurrent Malignant Gliomas

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Bevacizumab and Endothelium Dependent Vasodilation

BVZ1